Invention Grant
- Patent Title: Determining antigen-specific T-cells
-
Application No.: US16106867Application Date: 2018-08-21
-
Publication No.: US11261490B2Publication Date: 2022-03-01
- Inventor: Mark Klinger , Malek Faham
- Applicant: Adaptive Biotechnologies Corp.
- Applicant Address: US WA Seattle
- Assignee: Adaptive Biotechnologies Corp.
- Current Assignee: Adaptive Biotechnologies Corp.
- Current Assignee Address: US WA Seattle
- Agency: Bozicevic, Field & Francis LLP
- Agent Shweta Chandra
- Main IPC: C12Q1/6881
- IPC: C12Q1/6881

Abstract:
The invention is directed to methods for determining antigen-specific T cells. In some embodiments, methods of the invention may be implemented by the steps of reacting under interaction conditions one or more antigens with T cells in a plurality of subsets of a tissue sample, such as peripheral blood; sorting antigen-interacting T cells from other T cells; separately sequencing for each subset recombined nucleic acid encoding a segment of a TCR chain from a sample of T cells prior to exposure to antigen and from a sample of T cells isolated based on their interaction with antigen, thereby forming a clonotype profile for the former sample and the latter sample for each subset; and identifying as antigen-specific T cells those T cells associated with a clonotype whose frequency increases in the latter sample relative to its frequency in the former sample.
Public/Granted literature
- US20180355429A1 DETERMINING ANTIGEN-SPECIFIC T-CELLS Public/Granted day:2018-12-13
Information query
IPC分类: